Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Esperanza Merino's publication output changed over time?
ScholarIQpublication output · 2006–2025
Output grew0% over the shown period — from 1 works in 2006 to 1 in 2025.
1
1
2
1
2
2
1
1
20062012201720182020202120222025
What are the most-cited papers on Esperanza Merino?
ScholarIQmost cited works
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Óscar Moreno, Esperanza Merino, José‐Manuel León‐Ramírez, Mariano Andrés, José Manuel Ramos, J.J. Arenas-Jiménez, Santos Asensio Sánchez, Rosa María Sánchez Pérez, Paloma Ruiz-Torregrosa, Irene Rodríguez-Galán, Alexander Scholz, Antonio Amo-Lozano, Pilar González-de-la-Aleja, Vicente Boix, Joan Gil
S19579164. 2021708 CitationsOPEN ACCESS
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hongchao Pan, Richárd Pető, Ana María Henao-Restrepo, Marie‐Pierre Préziosi, Vasee Moorthy, Quarraisha Abdool Karim, Marissa Alejandria, César Hernàndez García, Marie-Paule Kiény, Reza Malekzadeh, Srinivas Murthy, K. Srinath Reddy, Mirta Roses Periago, Pierre Abi Hanna, Akaki Abutidze, Florence Ader, Abdullah Al-Bader, Almonther Alhasawi, Emma Allum, Adhra Al‐Mawali, Athari Alotaibi, Carlos Álvarez, Sheila Appadoo, Derk L. Arts, Abdullah M. Asiri, Pål Aukrust, Andreas Barratt‐Due, Abebe Genetu Bayih, H. Beaumont, Samir Bellani, Virginia Benassi, Balram Bhargava, Mattia Branca, Heike Cappel-Porter, Nery Cerrato, Fadima Cheick Haidara, Ting Soo Chow, Nadia Como, Joe Eustace, Tamar Gabunia, Patricia García, Sheela Godbole, Eduardo Gotuzzo, Laimonas Griškevičius, Rasha Hamra, Mariam Hassan, Mohamed Hassany, David W. Hutton, Irmansyah Irmansyah, Ligita Jančorienė, Faryal Khamis, Jana Kirwan, Suresh Kumar, Peter Lennon, Gustavo Lopardo, Patrick Lydon, Nicola Magrini, Suzana Manevska, Oriol Manuel, Sybil McGinty, Marco T. Medina, María Lucía Mesa Rubio, María Consuelo Miranda, Jeremy Nel, Estêvão Portela Nunes, Markus Perola, Antonio Portolés, Menaldi Rasmin, Aun Raza, Helen Rees, Paula Reges, Chris Rogers, Kolawole Salami, Marina I. Salvadori, Mamatha Sauermann, Narvina Sinani, Samba O. Sow, Jonathan A C Sterne, Milena Stevanoviкј, Evelina Tacconelli, Fernando Maltêz, Mekonnen Teferi, Kari A.O. Tikkinen, Sven Trelle, Tengiz Tsertsvadze, Hala Zaid, John-Arne Røttingen, Soumya Swaminathan, Michael P. Ryan, Nevila Gjermeni, Esmeralda Meta, Damián Águila, Ignacio Alonso, Marcos Altamirano, María López Álvarez, Rodrigo Alzola, Verónica Arce, Patricia Arribillaga, Rafael Ávila, Juan Pablo Balbuena
The Lancet. 2022406 CitationsOPEN ACCESS
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
Daniel Podzamczer, Elena Ferrer, Pochita Sanchez, José M. Gatell, Manel Crespo, Cesar Fisac, Montse Loncà, José Sanz, Jordí Niubó, Sergio Veloso, Josep M. Llibre, Pilar Barrufet, María A Ribas, Esperanza Merino, Esteban Ribera, Javier Martínez-Lacasa, Carlos Agustín Isidro Alonso, Miquel Aranda, Federico Pulido, Juan Berenguer, Antonio Delegido, Juan D Pedreira, Ana Lérida, Rafael Rubio, Luis del Río
S157460402. 2006137 Citations
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
Francisco M. Marty, Joan Vidal-Puigserver, Carol L. Clark, Sandeep K. Gupta, Esperanza Merino, Denis Garot, Marianne J. Chapman, Frédérique Jacobs, Eduardo Rodríguez-Noriega, Petr Husa, Denise Shortino, Helen Watson, Phillip J. Yates, Amanda Peppercorn
The Lancet Respiratory Medicine. 2017105 Citations
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Federico Pulido, Esteban Ribera, María Lagarde, Ignacio Valero, Rosario Palacios, José Antonio Iribarren, Antoni Payeras, Peré Domingo, José Sanz, Miguel Cervero, Adrián Curran, Francisco Javier Rodríguez‐Gómez, María Jesús Téllez, Pablo Ryan, Pilar Barrufet, Hernando Knobel, Antonio Rivero, Belén Alejos, María Yllescas, José Ramón Arribas, for the DUAL-GESIDA-8014-RIS-EST45 Study Group, José Ramón Arribas, Rocío Montejano, Juan González‐García, Marisa Montes, José Ignacio Bernardino, Ignacio Valero, Juan Castro, Mario Mayoral, Federico Pulido, María Lagarde, Otilia Bisbal, Mariano Matarranz, Asunción Hernando, Lourdes Domínguez, Rafael Rubio, Esteban Ribera, Adrián Curran, Jordi Navarro, Joaquín Burgos, I Ocaña, Vicenç Falcó, José Ramón Santos, Rosario Palacios, Ignacio Pérez, Carmen María González-Domenech, Maialen Ibarguren, Miguel Ángel Goenaga, Francisco Rodríguez-Arrondo, M. A. von Wichmann, Xabier Kortajarena, M.P. Carmona, H Son Llatzer, Antoni Payeras, Maison Abu Raya, Andrea Salom, Peré Domingo, M M Gutierrez, M. Gracia Mateo, M. A. Sambeat, José Sanz, J. de Miguel, E Casas, Alberto Arranz, Miguel Cervero, Rafael Torres, H Infanta Elena, Francisco Javier Rodríguez‐Gómez, J M Fajardó, Francisco Javier Martínez‐Marcos, María de la Paz Valverde Merino, Miguel Raffo, Ignacio Suárez-Lozano, H. Clínico, María Jesús Téllez, Jorge Vergas, Vicente Estrada, H Infanta Leonor, Pablo Ryan, Jesús Troya, Guillermo Cuevas, Victorino Diez-Viñas, Tamar Talaván, F Solís, H de Mataró, Pilar Barrufet, Lluís Force, Hanna Mar, Hernando Knobel, Alicia González, Edgar V. Lerma, J. Villar, H Reina Sofía, Antonio Rivero, Ángela Camacho, Isabel Machuca, Teresa Brieva, Antonio Rivero‐Juárez, JM Gatell, Jesús Domínguez-Rojas
S72350973. 2017102 CitationsOPEN ACCESS
Related on ScholarIQ
Universitat de Miguel Hernández d'Elx
Institution
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Paper
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Paper
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
Paper
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
Paper
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Paper